Details
Description
Inclusion Criteria
Exclusion Criteria
Details
Title Paroxysmal Hemoglobinuria Registry
IRB ALEX1Z11
CC 11-245
Hospital Main Campus
Stage N/A
Phase N/A
Disease Paroxysmal Nocturnal Hemoglobinuria (PNH)
Drug Soliris
Description
Primary- The PNH registry will collect data to evaluate safety data specific to the use of Soliris
- The PNH registry will collect data to characterize the progression of PNH as well as clinical outcomes, mortality and morbidity in Soliris and non-Soliris treated patients
- Raising PNH awareness in the medical community and subject/potential subject population
Inclusion Criteria
- PNH patients of any age, including minors, that are receiving Soliris or
- PNH patients of any age, including minors, that are not on Soliris treatment
- NOTE: PNH patients include all patients with a diagnosis of PNH or a detected PNH clone as defined in section 7.1
